Both in Pharmaceuticals
Ionis Pharmaceuticals vs Axsome Therapeutics
Over the past year IONS returned −45.1% and AXSM returned +2.8%; their daily moves had a correlation of 0.28.
IONS −45.1% AXSM +2.8%Growth of $1, one year, split-adjusted
| Metric | IONS | AXSM |
|---|---|---|
| Price | $40.42 | $139.61 |
| Market cap | $6.72B | $7.31B |
| Today | −1.99% | +2.65% |
| 1 month | −7.1% | −21.2% |
| 6 months | −46.3% | −37.4% |
| Year to date | −48.9% | −23.6% |
| 1 year | −45.6% | +3.4% |
| Revenue growth (YoY) | −40.7% | +51.9% |
| Gross margin | 99.0% | 93.1% |
| Net margin | −42.8% | −5.0% |
| P/E (TTM) | — | — |
| Price / sales | 7.7× | 8.5× |
| Net cash | $732.0M | $116.6M |
| Dividend yield | — | — |
| Volatility (60d) | 43.7% | 38.1% |
| Short % of float | 12.6% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).